Search research articles
Contact Us
Filters
Showing results (11-20 of 121) with videos related to
Page
of 13
Sort By:
Cancer Biology & Therapy
|
November 18, 2015
Antitumor effects and molecular mechanisms of ponatinib on endometrial cancer cells harboring activating FGFR2 mutations
Do-Hee Kim, Yeonui Kwak, Nam Doo Kim, et al.
European Journal of Medicinal Chemistry
|
February 1, 2025
Identification of Thieno[3,2-d]pyrimidine derivatives as potent and selective Janus Kinase 1 inhibitors
Younghoon Kim, Eunhye Jeon, Hyunwoo Ahn, et al.
Biochemical and Biophysical Research Communications
|
July 3, 2013
Identification of methyl violet 2B as a novel blocker of focal adhesion kinase signaling pathway in cancer cells
Hwan Kim, Nam Doo Kim, Jiyeon Lee, et al.
Biochemical and Biophysical Research Communications
|
September 3, 2020
The first small molecules capable of strongly suppressing proliferation of cancer cells harboring BRAF class I/II/III mutations
Seung-Hye Choi, Injae Shin, Namdoo Kim, et al.
Bioscience Reports
|
December 13, 2018
Procaspase activating compound 1 controls tetracycline repressor-regulated gene expression system
Chiman Song, Namkyoung Kim, Miri Park, et al.
Journal of Medicinal Chemistry
|
December 15, 2015
A Pyrazolo[3,4-d]pyrimidin-4-amine Derivative Containing an Isoxazole Moiety Is a Selective and Potent Inhibitor of RET Gatekeeper Mutants
Hojong Yoon, Yeonui Kwak, Seunghye Choi, et al.
European Journal of Medicinal Chemistry
|
August 29, 2025
Synthesis and biological evaluation of α-D-tocopherol derivatives as anticancer agents targeting mitochondrial metabolism
Younghoon Kim, Jungmin Kim, Kyubin Hwang, et al.
Bioorganic & Medicinal Chemistry Letters
|
September 10, 2013
Synthesis and biological evaluation of novel 3,4-diaryl lactam derivatives as triple reuptake inhibitors
Jung-eun Park, Chiman Song, Keehyun Choi, et al.
Neoplasia (New York, N.Y.)
|
December 5, 2021
Anti-cancer effects of 3,4-dihydropyrimido[4,5-d]pyrimidin-2(1H)-one derivatives on hepatocellular carcinoma harboring FGFR4 activation
Yunju Nam, Injae Shin, Younghoon Kim, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry
|
August 13, 2019
Identification of 1<i>H</i>-pyrazolo[3,4-b]pyridine derivatives as potent ALK-L1196M inhibitors
Yunju Nam, Dongkeun Hwang, Namdoo Kim, et al.
Page
of 13
Search research articles
Search
Showing results (11-20 of 121) with videos related to
Sort By:
Page
of 13
Cancer Biology & Therapy
|
November 18, 2015
Antitumor effects and molecular mechanisms of ponatinib on endometrial cancer cells harboring activating FGFR2 mutations
Do-Hee Kim, Yeonui Kwak, Nam Doo Kim, et al.
European Journal of Medicinal Chemistry
|
February 1, 2025
Identification of Thieno[3,2-d]pyrimidine derivatives as potent and selective Janus Kinase 1 inhibitors
Younghoon Kim, Eunhye Jeon, Hyunwoo Ahn, et al.
Biochemical and Biophysical Research Communications
|
July 3, 2013
Identification of methyl violet 2B as a novel blocker of focal adhesion kinase signaling pathway in cancer cells
Hwan Kim, Nam Doo Kim, Jiyeon Lee, et al.
Biochemical and Biophysical Research Communications
|
September 3, 2020
The first small molecules capable of strongly suppressing proliferation of cancer cells harboring BRAF class I/II/III mutations
Seung-Hye Choi, Injae Shin, Namdoo Kim, et al.
Bioscience Reports
|
December 13, 2018
Procaspase activating compound 1 controls tetracycline repressor-regulated gene expression system
Chiman Song, Namkyoung Kim, Miri Park, et al.
Journal of Medicinal Chemistry
|
December 15, 2015
A Pyrazolo[3,4-d]pyrimidin-4-amine Derivative Containing an Isoxazole Moiety Is a Selective and Potent Inhibitor of RET Gatekeeper Mutants
Hojong Yoon, Yeonui Kwak, Seunghye Choi, et al.
European Journal of Medicinal Chemistry
|
August 29, 2025
Synthesis and biological evaluation of α-D-tocopherol derivatives as anticancer agents targeting mitochondrial metabolism
Younghoon Kim, Jungmin Kim, Kyubin Hwang, et al.
Bioorganic & Medicinal Chemistry Letters
|
September 10, 2013
Synthesis and biological evaluation of novel 3,4-diaryl lactam derivatives as triple reuptake inhibitors
Jung-eun Park, Chiman Song, Keehyun Choi, et al.
Neoplasia (New York, N.Y.)
|
December 5, 2021
Anti-cancer effects of 3,4-dihydropyrimido[4,5-d]pyrimidin-2(1H)-one derivatives on hepatocellular carcinoma harboring FGFR4 activation
Yunju Nam, Injae Shin, Younghoon Kim, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry
|
August 13, 2019
Identification of 1<i>H</i>-pyrazolo[3,4-b]pyridine derivatives as potent ALK-L1196M inhibitors
Yunju Nam, Dongkeun Hwang, Namdoo Kim, et al.
Page
of 13